Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis

In this work, we aim to identify sensitive neurophysiological biomarkers of axonal degeneration in CIDP patients. A total of 16 CIDP patients, fulfilling the clinical and neurophysiological criteria for typical CIDP, treated with subcutaneous immunoglobulin (ScIg) (0.4 g/kg/week) were evaluated at b...

Full description

Bibliographic Details
Published in:Brain Sciences
Main Authors: Ricciardi, Dario, Amitrano, Federica, Coccia, Armando, Todisco, Vincenzo, Trojsi, Francesca, Tedeschi, Gioacchino, Cirillo, Giovanni
Format: Text
Language:English
Published: MDPI 2022
Subjects:
DML
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688174/
http://www.ncbi.nlm.nih.gov/pubmed/36358436
https://doi.org/10.3390/brainsci12111510
id ftpubmed:oai:pubmedcentral.nih.gov:9688174
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:9688174 2023-05-15T16:02:02+02:00 Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis Ricciardi, Dario Amitrano, Federica Coccia, Armando Todisco, Vincenzo Trojsi, Francesca Tedeschi, Gioacchino Cirillo, Giovanni 2022-11-07 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688174/ http://www.ncbi.nlm.nih.gov/pubmed/36358436 https://doi.org/10.3390/brainsci12111510 en eng MDPI http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688174/ http://www.ncbi.nlm.nih.gov/pubmed/36358436 http://dx.doi.org/10.3390/brainsci12111510 © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). CC-BY Brain Sci Article Text 2022 ftpubmed https://doi.org/10.3390/brainsci12111510 2022-11-27T02:05:28Z In this work, we aim to identify sensitive neurophysiological biomarkers of axonal degeneration in CIDP patients. A total of 16 CIDP patients, fulfilling the clinical and neurophysiological criteria for typical CIDP, treated with subcutaneous immunoglobulin (ScIg) (0.4 g/kg/week) were evaluated at baseline (before ScIg treatment) and after long-term treatment with ScIg (24 months) by clinical assessment scales, nerve conduction studies (NCS) and electromyography (EMG). Conventional and non-conventional neurophysiological parameters: motor unit potential (MUP) analysis, MUP thickness and size index (SI)] and interference pattern (IP) features were evaluated after long-term treatment (24 months) and compared with a population of 16 healthy controls (HC). An increase of distal motor latency (DML) and reduced compound motor action potential (CMAP) amplitude and area in CIDP patients suggest axonal damage of motor fibers, together with a significant increase of MUP amplitude, duration and area. Analysis of non-conventional MUP parameters shows no difference for MUP thickness; however, in CIDP patients, SI is increased and IP area and amplitude values are lower than HC. Despite clinical and neurophysiological improvement after ScIg treatment, neurophysiological analysis revealed axonal degeneration of motor fibers and motor unit remodeling. Correlation analysis shows that the axonal degeneration process is related to the diagnostic and therapeutic delay. MUP area and SI parameters can detect early signs of axonal degeneration, and their introduction in clinical practice may help to identify patients with the worst outcome. Text DML PubMed Central (PMC) Brain Sciences 12 11 1510
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Article
spellingShingle Article
Ricciardi, Dario
Amitrano, Federica
Coccia, Armando
Todisco, Vincenzo
Trojsi, Francesca
Tedeschi, Gioacchino
Cirillo, Giovanni
Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
topic_facet Article
description In this work, we aim to identify sensitive neurophysiological biomarkers of axonal degeneration in CIDP patients. A total of 16 CIDP patients, fulfilling the clinical and neurophysiological criteria for typical CIDP, treated with subcutaneous immunoglobulin (ScIg) (0.4 g/kg/week) were evaluated at baseline (before ScIg treatment) and after long-term treatment with ScIg (24 months) by clinical assessment scales, nerve conduction studies (NCS) and electromyography (EMG). Conventional and non-conventional neurophysiological parameters: motor unit potential (MUP) analysis, MUP thickness and size index (SI)] and interference pattern (IP) features were evaluated after long-term treatment (24 months) and compared with a population of 16 healthy controls (HC). An increase of distal motor latency (DML) and reduced compound motor action potential (CMAP) amplitude and area in CIDP patients suggest axonal damage of motor fibers, together with a significant increase of MUP amplitude, duration and area. Analysis of non-conventional MUP parameters shows no difference for MUP thickness; however, in CIDP patients, SI is increased and IP area and amplitude values are lower than HC. Despite clinical and neurophysiological improvement after ScIg treatment, neurophysiological analysis revealed axonal degeneration of motor fibers and motor unit remodeling. Correlation analysis shows that the axonal degeneration process is related to the diagnostic and therapeutic delay. MUP area and SI parameters can detect early signs of axonal degeneration, and their introduction in clinical practice may help to identify patients with the worst outcome.
format Text
author Ricciardi, Dario
Amitrano, Federica
Coccia, Armando
Todisco, Vincenzo
Trojsi, Francesca
Tedeschi, Gioacchino
Cirillo, Giovanni
author_facet Ricciardi, Dario
Amitrano, Federica
Coccia, Armando
Todisco, Vincenzo
Trojsi, Francesca
Tedeschi, Gioacchino
Cirillo, Giovanni
author_sort Ricciardi, Dario
title Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
title_short Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
title_full Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
title_fullStr Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
title_full_unstemmed Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis
title_sort neurophysiological hallmarks of axonal degeneration in cidp patients: a pilot analysis
publisher MDPI
publishDate 2022
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688174/
http://www.ncbi.nlm.nih.gov/pubmed/36358436
https://doi.org/10.3390/brainsci12111510
genre DML
genre_facet DML
op_source Brain Sci
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688174/
http://www.ncbi.nlm.nih.gov/pubmed/36358436
http://dx.doi.org/10.3390/brainsci12111510
op_rights © 2022 by the authors.
https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
op_rightsnorm CC-BY
op_doi https://doi.org/10.3390/brainsci12111510
container_title Brain Sciences
container_volume 12
container_issue 11
container_start_page 1510
_version_ 1766397673806495744